Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID:
Biomarker discovery study of DS-8201a, an anti-HER2-antibody drug conjugate, in randomized phase III trials (DS8201-A-U301, U302, U303) in unresectable and/or metastatic breast cancer and in patients receiving DS-8201a as standard of care treatment
Status
Open
Conditions
Other
Phases
Pilot
Age Group
Adult
Main Investiagtor
Crozier, Jennifer
Practice
Breast
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Secondary Trial ID Number
PA18-1100
Keywords
Observational